1
|
Fabiano V, Indrio F, Verduci E, Calcaterra V, Pop TL, Mari A, Zuccotti GV, Cullu Cokugras F, Pettoello-Mantovani M, Goulet O. Term Infant Formulas Influencing Gut Microbiota: An Overview. Nutrients 2021; 13:4200. [PMID: 34959752 PMCID: PMC8708119 DOI: 10.3390/nu13124200] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 11/19/2021] [Accepted: 11/20/2021] [Indexed: 02/05/2023] Open
Abstract
Intestinal colonization of the neonate is highly dependent on the term of pregnancy, the mode of delivery, the type of feeding [breast feeding or formula feeding]. Postnatal immune maturation is dependent on the intestinal microbiome implementation and composition and type of feeding is a key issue in the human gut development, the diversity of microbiome, and the intestinal function. It is well established that exclusive breastfeeding for 6 months or more has several benefits with respect to formula feeding. The composition of the new generation of infant formulas aims in mimicking HM by reproducing its beneficial effects on intestinal microbiome and on the gut associated immune system (GAIS). Several approaches have been developed currently for designing new infant formulas by the addition of bioactive ingredients such as human milk oligosaccharides (HMOs), probiotics, prebiotics [fructo-oligosaccharides (FOSs) and galacto-oligosaccharides (GOSs)], or by obtaining the so-called post-biotics also known as milk fermentation products. The aim of this article is to guide the practitioner in the understanding of these different types of Microbiota Influencing Formulas by listing and summarizing the main concepts and characteristics of these different models of enriched IFs with bioactive ingredients.
Collapse
Affiliation(s)
- Valentina Fabiano
- Department of Pediatrics, Vittore Buzzi Children’s Hospital, Università degli Studi di Milano, 20154 Milan, Italy; (V.F.); (E.V.); (V.C.); (A.M.); (G.V.Z.)
| | - Flavia Indrio
- Department of Medical and Surgical Sciences, University of Foggia, 71100 Foggia, Italy
- European Paediatric Association/Union of National European Paediatric Societies and Associations, 10115 Berlin, Germany; (T.L.P.); (F.C.C.); (M.P.-M.)
| | - Elvira Verduci
- Department of Pediatrics, Vittore Buzzi Children’s Hospital, Università degli Studi di Milano, 20154 Milan, Italy; (V.F.); (E.V.); (V.C.); (A.M.); (G.V.Z.)
| | - Valeria Calcaterra
- Department of Pediatrics, Vittore Buzzi Children’s Hospital, Università degli Studi di Milano, 20154 Milan, Italy; (V.F.); (E.V.); (V.C.); (A.M.); (G.V.Z.)
- Pediatric and Adolescent Unit, Department of Internal Medicine, University of Pavia, 27100 Pavia, Italy
| | - Tudor Lucian Pop
- European Paediatric Association/Union of National European Paediatric Societies and Associations, 10115 Berlin, Germany; (T.L.P.); (F.C.C.); (M.P.-M.)
- Second Paediatric Clinic, Department of Mother and Child, University of Medicine and Pharmacy Iuliu Hatieganu, 400177 Cluj-Napoca, Romania
| | - Alessandra Mari
- Department of Pediatrics, Vittore Buzzi Children’s Hospital, Università degli Studi di Milano, 20154 Milan, Italy; (V.F.); (E.V.); (V.C.); (A.M.); (G.V.Z.)
| | - Gian Vincenzo Zuccotti
- Department of Pediatrics, Vittore Buzzi Children’s Hospital, Università degli Studi di Milano, 20154 Milan, Italy; (V.F.); (E.V.); (V.C.); (A.M.); (G.V.Z.)
| | - Fugen Cullu Cokugras
- European Paediatric Association/Union of National European Paediatric Societies and Associations, 10115 Berlin, Germany; (T.L.P.); (F.C.C.); (M.P.-M.)
- Paediatric Gastroenterology, Hepatology and Nutrition, Cerrahpasa Medical Faculty, Istanbul University, Istanbul 34000, Turkey
| | - Massimo Pettoello-Mantovani
- European Paediatric Association/Union of National European Paediatric Societies and Associations, 10115 Berlin, Germany; (T.L.P.); (F.C.C.); (M.P.-M.)
- Department of Pediatrics, Scientific Institute ‘Casa Sollievo della Sofferenza’, University of Foggia, 71122 Foggia, Italy
- Association pour l’Activité et la Recherche Scìentifiques, EPA-UNEPSA/ARS, 2000 Neuchâtel, Switzerland
| | - Olivier Goulet
- Department of Paediatric Gastroenterology, and Nutrition, Intestinal Failure Rehabilitation Centre, National Reference Centre for Rare Digestive Diseases, Necker-Enfants Malades Hospital, Paris Centre University and Paris-Descartes School of Medicine, 75000 Paris, France;
| |
Collapse
|
2
|
The critical roles of iron during the journey from fetus to adolescent: Developmental aspects of iron homeostasis. Blood Rev 2021; 50:100866. [PMID: 34284901 DOI: 10.1016/j.blre.2021.100866] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 06/28/2021] [Accepted: 07/01/2021] [Indexed: 12/12/2022]
Abstract
Iron is indispensable for human life. However, it is also potentially toxic, since it catalyzes the formation of harmful oxidative radicals in unbound form and may facilitate pathogen growth. Therefore, iron homeostasis needs to be tightly regulated. Rapid growth and development require large amounts of iron, while (especially young) children are vulnerable to infections with iron-dependent pathogens due to an immature immune system. Moreover, unbalanced iron status early in life may have effects on the nervous system, immune system and gut microbiota that persist into adulthood. In this narrative review, we assess the critical roles of iron for growth and development and elaborate how the body adapts to physiologically high iron demands during the journey from fetus to adolescent. As a first step towards the development of clinical guidelines for the management of iron disorders in children, we summarize the unmet needs regarding the developmental aspects of iron homeostasis.
Collapse
|
3
|
Sumibcay TJ, Lee-Jayaram JJ, Yamamoto LG. Reducing Broad-Spectrum Antibiotic Treatment of Simple Group A Streptococcal Infections to Reduce Harm to the Microbiome. Cureus 2021; 13:e15629. [PMID: 34306841 PMCID: PMC8279917 DOI: 10.7759/cureus.15629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/13/2021] [Indexed: 11/05/2022] Open
Abstract
Background Broad-spectrum antibiotics disrupt the human microbiome resulting in a greater risk of harmful, long-term conditions that impact human health. Group A streptococcal (GAS) infections can be treated with penicillin. Objective We examined the treatment of simple GAS infections to assess the use of broad-spectrum antibiotics. Methods Smart relational database extraction queries from January 1, 2016 to July 10, 2019 (3.6 years) of patients less than 22 years old in a 4-hospital system electronic medical record (EMR). Results We found 1778 non-ED outpatients and 873 ED patients with simple GAS infections who were not allergic to penicillin. A total of 75% and 44% of non-ED and ED patients were treated with broad-spectrum antibiotics, respectively (p < 0.001). Older patients were treated with penicillin alone more frequently than younger age groups (p < 0.001). Conclusion These findings highlight opportunities for clinicians to reduce the utilization of broad-spectrum antibiotics for the treatment of simple GAS infections to reduce harm to the microbiome.
Collapse
Affiliation(s)
- Tyrone J Sumibcay
- Pediatrics, Kapi`olani Medical Center for Women & Children, Honolulu, USA
| | - Jannet J Lee-Jayaram
- Pediatrics, Kapi`olani Medical Center for Women & Children, Honolulu, USA.,Pediatric Emergency Medicine, University of Hawai'i, John A. Burns School of Medicine, Honolulu, USA
| | - Loren G Yamamoto
- Pediatrics, Kapi`olani Medical Center for Women & Children, Honolulu, USA.,Pediatric Emergency Medicine, University of Hawai'i, John A. Burns School of Medicine, Honolulu, USA
| |
Collapse
|
4
|
Ronan V, Yeasin R, Claud EC. Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood Development. Gastroenterology 2021; 160:495-506. [PMID: 33307032 PMCID: PMC8714606 DOI: 10.1053/j.gastro.2020.08.065] [Citation(s) in RCA: 114] [Impact Index Per Article: 28.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Revised: 08/25/2020] [Accepted: 08/29/2020] [Indexed: 12/11/2022]
Abstract
The composition of the intestinal microbiome affects health from the prenatal period throughout childhood, and many diseases have been associated with dysbiosis. The gut microbiome is constantly changing, from birth throughout adulthood, and several variables affect its development and content. Features of the intestinal microbiota can affect development of the brain, immune system, and lungs, as well as body growth. We review the development of the gut microbiome, proponents of dysbiosis, and interactions of the microbiota with other organs. The gut microbiome should be thought of as an organ system that has important effects on childhood development. Dysbiosis has been associated with diseases in children and adults, including autism, attention deficit hyperactivity disorder, asthma, and allergies.
Collapse
Affiliation(s)
- Victoria Ronan
- Department of Pediatrics, The University of Chicago, Chicago, Illinois
| | - Rummanu Yeasin
- Department of Pediatrics, The University of Chicago, Chicago, Illinois; Windsor University School of Medicine, Cayon, St Kitts, West Indies
| | - Erika C Claud
- Department of Pediatrics, The University of Chicago, Chicago, Illinois.
| |
Collapse
|
5
|
Olieman J, Kastelijn W. Nutritional Feeding Strategies in Pediatric Intestinal Failure. Nutrients 2020; 12:E177. [PMID: 31936393 PMCID: PMC7019898 DOI: 10.3390/nu12010177] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2019] [Revised: 12/31/2019] [Accepted: 01/04/2020] [Indexed: 12/20/2022] Open
Abstract
Intestinal failure is defined as a critical reduction of the gut mass or function, below the minimum needed to absorb nutrients and fluids. The ultimate goal in intestinal failure is to promote bowel adaptation and reach enteral autonomy while a healthy growth and development is maintained. The condition is heterogeneous and complex. Therefore, recommendations for the type and duration of parenteral, enteral, and oral nutrition are variable, with the child's age as an additional key factor. The aim of this review is to provide an overview of nutritional feeding strategies in this heterogeneous population. Different perspectives on nutritional management, nutrition and adaptation, and microbiome and nutrition will be discussed.
Collapse
Affiliation(s)
- Joanne Olieman
- Department of Internal Medicine, Division of Dietetics, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 40, 3015 GD Rotterdam, The Netherlands;
| | | |
Collapse
|
6
|
Szajewska H. Gut microbiota is a hot and fast-moving topic, and paediatricians need to monitor the latest developments. Acta Paediatr 2019; 108:1934-1935. [PMID: 31490568 DOI: 10.1111/apa.14960] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Hania Szajewska
- Department of Paediatrics The Medical University of Warsaw Warsaw Poland
| |
Collapse
|